Neuberger Berman Group’s Collegium Pharmaceutical COLL Stock Holding History

Neuberger Berman Group’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-103,933	Closed	-$2.45M	–	1774
2021 Q2	$2.45M	Buy	103,933 +1,399	+1%	+$32.3K	﹤0.01%	1125
2021 Q1	$2.43M	Buy	102,534 +1,534	+2%	+$36.4K	﹤0.01%	1112
2020 Q4	$2.02M	Hold	101,000	–	–	﹤0.01%	1106
2020 Q3	$2.1M	Hold	101,000	–	–	﹤0.01%	1053
2020 Q2	$1.77M	Buy	101,000 +25,000	+33%	+$489K	﹤0.01%	1027
2020 Q1	$1.24M	Buy	+76,000	New	+$1.57M	﹤0.01%	1050
2017 Q1	–	Sell	-20,000	Closed	-$311K	–	1596
2016 Q4	$311K	Buy	+20,000	New	+$332K	﹤0.01%	1405
2016 Q3	–	Sell	-20,000	Closed	-$237K	–	1596
2016 Q2	$237K	Buy	+20,000	New	+$330K	﹤0.01%	1421

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Neuberger Berman Group's COLL Position: Q3 2021 in Review

Neuberger Berman Group sold out of Collegium Pharmaceutical (COLL) in Q3 2021, closing a stake of 103,933 shares — an estimated $2.45M sold.

Neuberger Berman Group first reported a position in COLL in Q2 2016 and held it in 8 quarters. The position peaked at $2.45M in Q2 2021. 154 funds tracked by Wall St. Rank hold COLL as of Q3 2021.

Neuberger Berman Group reported no remaining Collegium Pharmaceutical position as of Q3 2021 after selling out during the quarter.
Neuberger Berman Group sold 103,933 Collegium Pharmaceutical shares in Q3 2021, an estimated $2.45M.
Neuberger Berman Group first reported a position in Collegium Pharmaceutical in Q2 2016 and held it in 8 quarters.
Neuberger Berman Group's Collegium Pharmaceutical position peaked at $2.45M in Q2 2021.
154 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2021.

Based on Neuberger Berman Group's 13F filing for Q3 2021, filed 12 Nov 2021.